MD Anderson is home to the leading cancer research institutes in the nation. With expertise in cancer prevention, risk assessment and the advancing of applied sciences to cancer research, the institutes at MD Anderson are unified in their goals to reduce risk and prevent cancer through science.
James P. Allison Institute
The James P. Allison Institute is a visionary research and innovation hub created to conduct groundbreaking science that integrates immunobiology across all disciplines.
Duncan Family Institute for Cancer Prevention and Risk Assessment
The Duncan Family Institute serves to foster collaboration aimed at breaking new ground in cancer prevention.
Institute for Applied Cancer Science
The aim of the Institute for Applied Cancer Science (IACS) is to apply scientific knowledge of mechanisms driving tumor development and maintenance into the development of impactful small molecule cancer therapies.
Institute for Cancer Care Innovation
The Institute for Cancer Care Innovation (ICCI) studies new and existing models of cancer care delivery and reimbursement. Its programs are based around the principles of value-based health care delivery that focuses on the outcomes and costs of care.
Institute for Data Science in Oncology
The Institute for Data Science in Oncology (IDSO) integrates the most advanced computational and data science approaches with MD Anderson's extensive scientific and clinical expertise to significantly improve patients' lives by transforming cancer care and research.
Sheikh Khalifa Zayed al Nahyan Institute for Personalized Cancer Therapy
The MD Anderson Sheikh Khalifa Zayed al Nahyan Institute for Personalized Cancer Therapy provides personalized cancer therapy for all of our patients and defines the new standard of patient care by improving outcomes and reducing costs.